scorecardresearch
Friday, August 29, 2025
TopicCovaxin

Topic: Covaxin

First batch of Covaxin from Bharat Biotech’s new plant in Gujarat released

The central government had earlier this month given approval to Bharat Biotech's Ankleshwar-based plant to produce Covaxin.

India to have 18-22 crore vaccine doses by September, ZyCoV D could take longer to hit market

The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.

Covid vaccines for children could be available by September, Bharat Biotech & NIV say

Bharat Biotech CMD Dr Krishna Ella said final phase of clinical trial is over & they hope to get licence soon. NIV Director Dr Priya Abraham said vaccines may be available by Sept.

Health Minister Mansukh Mandaviya meets WHO’s Soumya Swaminathan to discuss Covaxin approval

Covaxin had earlier this month received a certificate of Good Manufacturing Practice compliance from Hungary, which paved a way for another significant milestone for Bharat Biotech.

India’s drug regulator approves study on mixing of Covaxin, Covishield vaccine doses

The Central Drugs Standard Control Organisation on 29 July had recommended granting permission to the study that will be conducted by the Christian Medical College in Vellore.

Covishield shot followed by Covaxin safe, provides better immunogenicity, finds ICMR study

Researchers studied 18 cases where recipients were administered a first dose of Covishield, and “inadvertently” received Covaxin as the second dose.

J&J Covid vaccine gets emergency use nod in India. Here’s how the single-dose jab works

J&J became the fifth vaccine to get an emergency nod in the country, after Covishield, Covaxin, Sputnik V and Moderna.

Facilities at Bharat Biotech to be augmented to increase Covaxin supply, Mandaviya says

In a written reply to Rajya Sabha Friday, Health Minister Mansukh Mandaviya said that three Public Sector Enterprises will also be supported to manufacture Covaxin.

Every Covaxin batch undergoes over 200 tests, Bharat Biotech says over quality concerns

The statement from Hyderabad-based Covid vaccine manufacturer comes after reports surfaced claiming that Covaxin's test batches from the Bengaluru plant were not satisfactory.

Covaxin receives first Good Manufacturing Practice certificate in EU from Hungary

The approval came from the National Institute of Pharmacy and Nutrition Hungary and it marks the first compliance certificate received by Bharat Biotech from European regulators.

On Camera

How economic planning stifled India’s growth and talent

The Indian planning system did not encourage individuals based on ‘what they knew’, but on ‘whom they knew’. Many left for countries that recognised their talent.

All bets off as online gaming bill shakes industry & key players suspend ‘gambling’ on their platforms

The new law, which the government has framed as a moral duty, forced major platforms like Dream11 & Zupee to shut operations, wiping out hundreds of crores in market capitalisation. 

Post-Sindoor, joint doctrine tasks Special Forces with fighting info warfare & countering propaganda

Joint Doctrine for Special Forces Operations, released Wednesday, also outlines plans for the future expansion of AFSOD and the creation of Joint Service Training Institutes.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.